Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  ABIOMED, Inc.    ABMD

ABIOMED, INC. (ABMD)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Abiomed : invests in Israeli medical device maker Magenta

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/28/2017 | 01:06pm CEST

JERUSALEM (Reuters) - Israeli medical device company Magenta Medical said on Thursday it has raised $15 million in funding led by Massachusetts-based Abiomed Inc (>> ABIOMED, Inc.), a maker of catheter-based heart pumps, and venture capital firm Pitango.

JERUSALEM (Reuters) - Israeli medical device company Magenta Medical said on Thursday it has raised $15 million in funding led by Massachusetts-based Abiomed Inc (>> ABIOMED, Inc.), a maker of catheter-based heart pumps, and venture capital firm Pitango.

Japanese venture capital group JAFCO and a group of cardiovascular experts also invested in the round.

The Israeli startup is developing an apparatus for treating acute heart failure which it says can alleviate congestion faster and more safely than diuretics alone. Heart failure afflicts approximately 6.5 million people in the United States alone.

Ehud Schwammenthal, Magenta's co-founder and chief medical officer, said the company's first product was in clinical trials in Europe. The funding, he said, will allow the firm to expand the clinical programme, with the goal of getting approval in Europe and a second study going in the United States.

(Reporting by Dan Pleck; Editing by Tova Cohen)

Stocks treated in this article : ABIOMED, Inc., Medtronic PLC
Stocks mentioned in the article
ChangeLast1st jan.
MEDTRONIC PLC -0.55% 86.13 Delayed Quote.7.47%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ABIOMED, INC.
05/29Abiomed to Present at the Jefferies 2018 Healthcare Conference
GL
05/24ABIOMED : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
AQ
05/16ABIOMED : Federal Contracts Awarded by Federal Agencies in Texas (May 16)
AQ
05/16ABIOMED : MILITARY $50,000 Federal Contract Awarded to Abiomed
AQ
05/09ABIOMED : Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year R..
AQ
05/03ABIOMED (NASDAQ : ABMD) reported earnings of $0.80 per share beating Walls Stree..
AQ
05/03ABIOMED : Fiscal 4Q Earnings Snapshot
AQ
05/03ABIOMED INC : Results of Operations and Financial Condition, Financial Statement..
AQ
05/03ABIOMED : Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year R..
GL
04/25ABIOMED INC : Other Events (form 8-K)
AQ
More news
News from SeekingAlpha
06/12Discovery Is Undervalued - Cramer's Lightning Round (6/11/18) 
06/08STOCK EXCHANGE : Do You Start The Day With A Trading Plan? 
06/06Abiomed Is All Set For A Continued Upward Ride In 2018 
06/05BY THE NUMBERS : Consistent Growth Leaders With Strong Fundamentals 
06/01New And Old Investing Stories To Be Told 
Financials ($)
Sales 2019 768 M
EBIT 2019 222 M
Net income 2019 162 M
Finance 2019 526 M
Yield 2019 -
P/E ratio 2019 125,15
P/E ratio 2020 94,57
EV / Sales 2019 25,0x
EV / Sales 2020 19,2x
Capitalization 19 710 M
Chart ABIOMED, INC.
Duration : Period :
ABIOMED, Inc. Technical Analysis Chart | ABMD | US0036541003 | 4-Traders
Technical analysis trends ABIOMED, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 405 $
Spread / Average Target -7,9%
EPS Revisions
Managers
NameTitle
Michael R. Minogue Chairman, President & Chief Executive Officer
David M. Weber Chief Operating Officer
Todd A. Trapp Chief Financial Officer & Vice President
Thorsten Siess Chief Technology Officer
Seth Bilazarian Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ABIOMED, INC.136.69%19 710
THERMO FISHER SCIENTIFIC13.65%85 622
DANAHER CORPORATION7.77%70 744
INTUITIVE SURGICAL34.45%55 591
BOSTON SCIENTIFIC CORPORATION32.96%44 554
ILLUMINA32.16%42 461